. "468592" . . "V" . "Surgical Treatment of Infective Endocarditis: 8Year Experience"@en . . "145" . . . . . "Chirurgick\u00E1 l\u00E9\u010Dba aktivn\u00ED infek\u010Dn\u00ED endokarditidy: 8let\u00E9 zku\u0161enosti"@cs . . . "Chirurgick\u00E1 l\u00E9\u010Dba aktivn\u00ED infek\u010Dn\u00ED endokarditidy: 8let\u00E9 zku\u0161enosti"@cs . "RIV/00843989:_____/06:00013342" . . "Soubor tvo\u0159\u00ED 57 nemocn\u00FDch s aktivn\u00ED infek\u010Dn\u00ED endokarditidou (IE) operovan\u00FDch v obdob\u00ED od 1/1998 do 12/2005. Nej\u010Dast\u011Bj\u0161\u00ED etiologick\u00E9 agens \u2013 stafylokoky (28,1 %) a streptokoky (19,3 %). Nej\u010Dast\u011Bji posti\u017Eena aort\u00E1ln\u00ED chlope\u0148 (26 p\u0159\u00EDpad\u016F), d\u00E1le mitr\u00E1ln\u00ED (21), aort\u00E1ln\u00ED i mitr\u00E1ln\u00ED (7), trikuspid\u00E1ln\u00ED (3). P\u0159eva\u017Eovaly IE nativn\u00EDch chlopn\u00ED nad protetick\u00FDmi (49 vs. 8). IE byla obvykle \u0159e\u0161ena n\u00E1hradou chlopn\u011B mechanickou prot\u00E9zou \u2013 45x, bioprot\u00E9za byla pou\u017Eita u 13 nemocn\u00FDch, plastika mitr\u00E1ln\u00ED nebo trikuspid\u00E1ln\u00ED chlopn\u011B byla provedena v 6 p\u0159\u00EDpadech. U p\u0159e\u017Eiv\u0161\u00EDch nemocn\u00FDch do\u0161lo po operaci k signifikantn\u00EDmu zlep\u0161en\u00ED funk\u010Dn\u00ED t\u0159\u00EDdy NYHA (z NYHA III\u2013IV na I\u2013II). Rekurence endokarditidy \u010Dinila 7 %. T\u0159icetidenn\u00ED mortalita byla 15,8 %, celkov\u00E1 mortalita 28,1 % p\u0159i dob\u011B sledov\u00E1n\u00ED 0,5\u201390 (medi\u00E1n 40) m\u011Bs\u00EDc\u016F. Relativn\u011B vysok\u00E1 30denn\u00ED mortalita je akceptovateln\u00E1, nebo\u0165 operace v aktivn\u00ED f\u00E1zi je vynucena z\u00E1va\u017En\u00FDmi komplikacemi a umo\u017E\u0148uje sn\u00ED\u017Eit p\u0159edpokl\u00E1danou mortalitu p\u0159i konzervativn\u00ED l\u00E9\u010Db\u011B." . "Surgical Treatment of Infective Endocarditis: 8Year Experience"@en . "CZ - \u010Cesk\u00E1 republika" . "infective endocarditis; surgery; valve replacement; valve repair"@en . . "[F5125E38384A]" . . "RIV/00843989:_____/06:00013342!RIV09-MZ0-00843989" . "9" . "Kolek, Martin" . "Chirurgick\u00E1 l\u00E9\u010Dba aktivn\u00ED infek\u010Dn\u00ED endokarditidy: 8let\u00E9 zku\u0161enosti" . . "Fifty seven patients with active infective endocarditis (IE) underwent surgery between January 1998 and December 2005. The most frequent causative agents were staphylococci \u2013 28.1% and streptococci \u2013 19.3%. Aortic IE was the most common (26 cases), followed by mitral IE (21), both aortic and mitral IE (7) and tricuspid IE (3). Native valve endocarditis prevailed over the prosthetic ones \u2013 49 vs. 8. Surgery was most often performed using a mechanical prosthesis (45 cases), bioprostheses were implanted in 13 patients and 6 patients underwent mitral or tricuspid valve repair. Surgery was followed by a significant shift from classes III and IV to I and II of NYHA classification. Recurrent IE developed in 7%. Thirty-day mortality was 15.8%; the overall mortality was 28.1% (follow up 0.5 to 90 months (median, 40)). Relatively high 30-day mortality is acceptable because the surgery in active phase is enforced by life-threatening complications and it also reduces assumed mortality at conservat"@en . "7"^^ . "Chirurgick\u00E1 l\u00E9\u010Dba aktivn\u00ED infek\u010Dn\u00ED endokarditidy: 8let\u00E9 zku\u0161enosti" . "\u010Casopis l\u00E9ka\u0159\u016F \u010Desk\u00FDch" . . "2"^^ . . "2"^^ . "Br\u00E1t, Radim" . "Soubor tvo\u0159\u00ED 57 nemocn\u00FDch s aktivn\u00ED infek\u010Dn\u00ED endokarditidou (IE) operovan\u00FDch v obdob\u00ED od 1/1998 do 12/2005. Nej\u010Dast\u011Bj\u0161\u00ED etiologick\u00E9 agens \u2013 stafylokoky (28,1 %) a streptokoky (19,3 %). Nej\u010Dast\u011Bji posti\u017Eena aort\u00E1ln\u00ED chlope\u0148 (26 p\u0159\u00EDpad\u016F), d\u00E1le mitr\u00E1ln\u00ED (21), aort\u00E1ln\u00ED i mitr\u00E1ln\u00ED (7), trikuspid\u00E1ln\u00ED (3). P\u0159eva\u017Eovaly IE nativn\u00EDch chlopn\u00ED nad protetick\u00FDmi (49 vs. 8). IE byla obvykle \u0159e\u0161ena n\u00E1hradou chlopn\u011B mechanickou prot\u00E9zou \u2013 45x, bioprot\u00E9za byla pou\u017Eita u 13 nemocn\u00FDch, plastika mitr\u00E1ln\u00ED nebo trikuspid\u00E1ln\u00ED chlopn\u011B byla provedena v 6 p\u0159\u00EDpadech. U p\u0159e\u017Eiv\u0161\u00EDch nemocn\u00FDch do\u0161lo po operaci k signifikantn\u00EDmu zlep\u0161en\u00ED funk\u010Dn\u00ED t\u0159\u00EDdy NYHA (z NYHA III\u2013IV na I\u2013II). Rekurence endokarditidy \u010Dinila 7 %. T\u0159icetidenn\u00ED mortalita byla 15,8 %, celkov\u00E1 mortalita 28,1 % p\u0159i dob\u011B sledov\u00E1n\u00ED 0,5\u201390 (medi\u00E1n 40) m\u011Bs\u00EDc\u016F. Relativn\u011B vysok\u00E1 30denn\u00ED mortalita je akceptovateln\u00E1, nebo\u0165 operace v aktivn\u00ED f\u00E1zi je vynucena z\u00E1va\u017En\u00FDmi komplikacemi a umo\u017E\u0148uje sn\u00ED\u017Eit p\u0159edpokl\u00E1danou mortalitu p\u0159i konzervativn\u00ED l\u00E9\u010Db\u011B."@cs . "0008-7335" . .